Adrenocortical Carcinoma - 9 Studies Found
| Completed |
: Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma : Adrenocortical Carcinoma : 2006-05-08 : Drug: cisplatin, taxotere cisplatin 75 mg/m2 Taxotere 75 mg/m2 |
| Terminated |
: S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery : Adrenocortical Carcinoma : 1999-11-01 :
|
| Active, not recruiting |
: Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma :
: 2007-04-04 |
| Completed |
: A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection : Adrenal Cortical Carcinoma : 1999-11-03 : Drug: doxorubicin, vincristine, and etoposide with mitotane |
| Completed |
: A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent : Neoplasms : 2005-12-12 : Drug: ADH -1 (Exherin™) |
| Completed |
: Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor) : Solid Tumors : 2013-01-14 : Drug: Avelumab Avelumab will be administered in study location using a protocol-defined dose escalation |
| Completed |
: Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma : Adrenocortical Carcinoma : 2025-08-31 : All participants will first undergo ablative RT |
| Completed |
: Phase 1 Study of 68Ga-R8760 : Adrenocortical Carcinoma : 2025-08-31 : PET/CT imaging at predefined timepoints |
| Completed |
: A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma : Adrenocortical Carcinoma : 2025-08-31 : Given by PO |